The start-up aims to disrupt the bioengineering industry through a game-changing, AI-first approach, in which the tech drives the direction of the science. Within conventional bioengineering companies, developing potential ingredient strains can take between 4-10 years and cost millions, with no guarantees of success, but this new approach slashes timings to mere months, at a fraction of the usual cost outlay.
This approach will create affordable, scalable, and sustainable ingredients, created through biofermentation, that producers can use in the everyday items the world relies on. These ingredients will replace environmentally harmful chemicals and ingredients such as acetone, palm oil or isoprene, which are typically produced from fossil fuels, or hyper intensive farming.
Investors in this seed round include high profile names such as Project A, Seedcamp, Zero Carbon Capital, UK Innovation and Science Seed Fund, Gaingels and several expert angels, rolled up through HackCapital.
The company is founded by Dr. Russ Tucker (who previously founded UK cultivated meat pioneer Ivy Farm), Dr. James Allen and Dr. Satnam Surae, and is based in King’s Cross, London. Together the three founders bring commercial, scientific and tech expertise to provide a fully rounded solution to the market.
Since its beginnings in late 2022, twig has grown to a team of ten and has already tested thousands of strains through their automated platform in just five short months in the lab.